Vol 2022, No 9 (2022)

Table of Contents

Licensing

Zealand Pharma Signs Licensing Agreement with Novo Nordisk for Zegalogue® Abstract pdf html
Ayush Saxena
GSK Pays US$66 M Upfront for Spero’s Late-Stage Antibiotic Abstract pdf html
Lucy Haggerty

Mergers & Acquisitions

Roche Acquires Good Therapeutics for US$250 M Upfront Abstract pdf html
Lucy Haggerty
Novo Nordisk to Acquire Forma Therapeutics for US$1.1 B Abstract pdf html
Ashish Tripathi
Genfit Buys Versantis to Rebuild its Liver Disease Portfolio Abstract pdf html
Lucy Haggerty


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.